Arrakis Therapeutics Stock

arrakistx.comHealthcareFounded: 2015Funding to Date: $113.5MM

Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.

Register for Details

For more details on financing and valuation for Arrakis Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Arrakis Therapeutics.

Register Today

Team

Management Team

Daniel Koerwer
Chief Business Officer
Heather Lounsbury
Vice President of Business & Technical Operations
Jennifer Petter Ph.D
Co-Founder & Chief Scientific Officer
Rajesh Parekh Ph.D
Co-Founder & Board Member
Michael Gilman Ph.D
Chief Executive Officer & Chairman
Alan Walts Ph.D
Co-Founder & Board Member
James Barsoum Ph.D
Senior Vice President of Biology
Henri Termeer
Co-Founder

Board Members

Carolyn Green
Matthew Cohen Ph.D
Osage Venture Partners
Rajesh Parekh Ph.D
Alan Walts Ph.D
Jakob Loven Ph.D
Nextech Invest
Nikola Trbovic Ph.D
Pfizer Ventures
Colleen Cuffaro Ph.D
Canaan Partners
Elaine Jones Ph.D
Pfizer Ventures
Peter Worland Ph.D
Celgene
Richard Gaster MD
venBio
Michael Gilman Ph.D
Timothy Shannon MD
Canaan Partners

Other companies like Arrakis Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM
Sector
Last Round Est. Valuation
$4.8B